NEWARK, DE / ACCESSWIRE / June 12, 2023 / According to Future Market Insight, the global ophthalmic eye drops market is likely to reach US$ 16.21 Billion by 2033, registering a CAGR of 4.2%. This is a ...

The 2026 High Five Awards honor Capital Ophthalmic and four top industry peers for excellence in critical eye care ...

The Global Ophthalmic Eye Drops Industry emerges as a beacon of growth, casting a radiant light on the expansive landscape of the healthcare industry. Propelled by its immense potential, the market is ...

Former Novartis subsidiary Alcon, after targeting the pharmaceutical eye drop scene with a trio of recent drug purchases, is adding another pair of arrows to its ophthalmic quiver. And this time, the ...

Credit: Alcon. The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors. Tryptyr significantly improved tear production compared with ...

Artificial expiration dates on eye drops in ophthalmology clinics result in significant waste in terms of medication, plastic, and cost, according to a study presented at the annual meeting of the ...

Eyesight Ophthalmic Services, Northern New England’s leading provider of eye care for adults and children, is pleased to announce that its Exeter office will relocate on June 22 from its longtime home ...

The authors describe some cases of container closure design flaws and actions taken by FDA to mitigate safety risks and increase patient acceptability. Many ophthalmic diseases and eye irritations are ...

The enormous potential of the worldwide market for Ophthalmic Eye Drops Market shines brilliantly, illuminating the huge healthcare sector. In 2023, this market is anticipated to reach an astounding ...

To investigate the long-term results of 3% diquafosol ophthalmic solution as an alternative therapy to existing ophthalmic solutions, including topical immunosuppression, for the treatment of dry eye ...